CAAS Capital Management’s Exelixis EXEL Stock Holding History

CAAS Capital Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-32,000	Closed	-$513K	–	777
2022 Q4	$513K	Buy	+32,000	New	+$522K	0.03%	419

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAAS Capital Management's EXEL Position: Q1 2023 in Review

CAAS Capital Management sold out of Exelixis (EXEL) in Q1 2023, closing a stake of 32,000 shares — an estimated $513K sold.

CAAS Capital Management first reported a position in EXEL in Q4 2022 and held it in 1 quarter. The position peaked at $513K in Q4 2022. 363 funds tracked by Wall St. Rank hold EXEL as of Q1 2023.

CAAS Capital Management reported no remaining Exelixis position as of Q1 2023 after selling out during the quarter.
CAAS Capital Management sold 32,000 Exelixis shares in Q1 2023, an estimated $513K.
CAAS Capital Management first reported a position in Exelixis in Q4 2022 and held it in 1 quarter.
CAAS Capital Management's Exelixis position peaked at $513K in Q4 2022.
363 funds tracked by Wall St. Rank held Exelixis as of Q1 2023.

Based on CAAS Capital Management's 13F filing for Q1 2023, filed 15 May 2023.